Mallika L Mendu1, Louise I Schneider2, Ayal A Aizer3, Karandeep Singh4, David E Leaf4, Thomas H Lee5, Sushrut S Waikar4. 1. Division of Renal Medicine and mmendu@partners.org. 2. Division of General Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; 3. Harvard Radiation Oncology Program, Boston, Massachusetts; and. 4. Division of Renal Medicine and. 5. Division of General Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Press Ganey Associates, Inc., Boston, Massachusetts.
Abstract
BACKGROUND AND OBJECTIVES: CKD is associated with significant morbidity, mortality, and financial burden. Practice guidelines outlining CKD management exist, but there is limited application of these guidelines. Interventions to improve CKD guideline adherence have been limited. This study evaluated a new CKD checklist (a tool outlining management guidelines for CKD) to determine whether implementation in an academic primary care clinic improved adherence to guidelines. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: During a 1-year period (August 2012-August 2013), a prospective study was conducted among 13 primary care providers (PCPs), four of whom were assigned to use a CKD checklist incorporated into the electronic medical record during visits with patients with CKD stages 1-4. All providers received education regarding CKD guidelines. The intervention and control groups consisted of 105 and 263 patients, respectively. Adherence to CKD management guidelines was measured. RESULTS: A random-effects logistic regression analysis was performed to account for intra-group correlation by PCP assignment and adjusted for age and CKD stage. CKD care improved among patients whose PCPs were assigned to the checklist intervention compared with controls. Patients in the CKD checklist group were more likely than controls to have appropriate annual laboratory testing for albuminuria (odds ratio [OR], 7.9; 95% confidence interval [95% CI], 3.6 to 17.2), phosphate (OR, 3.5; 95% CI, 1.5 to 8.3), and parathyroid hormone (OR, 8.1; 95% CI, 4.8 to 13.7) (P<0.001 in all cases). Patients in the CKD checklist group had higher rates of achieving a hemoglobin A1c target<7% (OR, 2.7; 95% CI, 1.4 to 5.1), use of an angiotensin-converting enzyme inhibitor or angiotensin-receptor blocker (OR, 2.1; 95% CI, 1.0 to 4.2), documentation of avoidance of nonsteroidal anti-inflammatory drugs (OR, 41.7; 95% CI, 17.8 to 100.0), and vaccination for annual influenza (OR, 2.1; 95% CI, 1.1 to 4.0) and pneumococcus (OR, 4.7; 95% CI, 2.6 to 8.6) (P<0.001 in all cases). CONCLUSIONS: Implementation of a CKD checklist significantly improved adherence to CKD management guidelines and delivery of CKD care.
BACKGROUND AND OBJECTIVES: CKD is associated with significant morbidity, mortality, and financial burden. Practice guidelines outlining CKD management exist, but there is limited application of these guidelines. Interventions to improve CKD guideline adherence have been limited. This study evaluated a new CKD checklist (a tool outlining management guidelines for CKD) to determine whether implementation in an academic primary care clinic improved adherence to guidelines. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: During a 1-year period (August 2012-August 2013), a prospective study was conducted among 13 primary care providers (PCPs), four of whom were assigned to use a CKD checklist incorporated into the electronic medical record during visits with patients with CKD stages 1-4. All providers received education regarding CKD guidelines. The intervention and control groups consisted of 105 and 263 patients, respectively. Adherence to CKD management guidelines was measured. RESULTS: A random-effects logistic regression analysis was performed to account for intra-group correlation by PCP assignment and adjusted for age and CKD stage. CKD care improved among patients whose PCPs were assigned to the checklist intervention compared with controls. Patients in the CKD checklist group were more likely than controls to have appropriate annual laboratory testing for albuminuria (odds ratio [OR], 7.9; 95% confidence interval [95% CI], 3.6 to 17.2), phosphate (OR, 3.5; 95% CI, 1.5 to 8.3), and parathyroid hormone (OR, 8.1; 95% CI, 4.8 to 13.7) (P<0.001 in all cases). Patients in the CKD checklist group had higher rates of achieving a hemoglobin A1c target<7% (OR, 2.7; 95% CI, 1.4 to 5.1), use of an angiotensin-converting enzyme inhibitor or angiotensin-receptor blocker (OR, 2.1; 95% CI, 1.0 to 4.2), documentation of avoidance of nonsteroidal anti-inflammatory drugs (OR, 41.7; 95% CI, 17.8 to 100.0), and vaccination for annual influenza (OR, 2.1; 95% CI, 1.1 to 4.0) and pneumococcus (OR, 4.7; 95% CI, 2.6 to 8.6) (P<0.001 in all cases). CONCLUSIONS: Implementation of a CKD checklist significantly improved adherence to CKD management guidelines and delivery of CKD care.
Authors: Raquel F Charles; Neil R Powe; Bernard G Jaar; Misty U Troll; Rulan S Parekh; L Ebony Boulware Journal: Am J Kidney Dis Date: 2009-04-15 Impact factor: 8.860
Authors: Alex B Haynes; Thomas G Weiser; William R Berry; Stuart R Lipsitz; Abdel-Hadi S Breizat; E Patchen Dellinger; Teodoro Herbosa; Sudhir Joseph; Pascience L Kibatala; Marie Carmela M Lapitan; Alan F Merry; Krishna Moorthy; Richard K Reznick; Bryce Taylor; Atul A Gawande Journal: N Engl J Med Date: 2009-01-14 Impact factor: 91.245
Authors: Mark Rutkowski; Wendy Mann; Stephen Derose; David Selevan; Noel Pascual; Jean Diesto; Peter Crooks Journal: Am J Kidney Dis Date: 2009-03 Impact factor: 8.860
Authors: Josef Coresh; Elizabeth Selvin; Lesley A Stevens; Jane Manzi; John W Kusek; Paul Eggers; Frederick Van Lente; Andrew S Levey Journal: JAMA Date: 2007-11-07 Impact factor: 56.272
Authors: Sankar D Navaneethan; Stacey E Jolly; Jesse D Schold; Susana Arrigain; Georges Nakhoul; Victoria Konig; Jennifer Hyland; Yvette K Burrucker; Priscilla Davis Dann; Barbara H Tucky; John Sharp; Joseph V Nally Journal: Clin J Am Soc Nephrol Date: 2017-08-04 Impact factor: 8.237
Authors: Paul E Drawz; Patrick Archdeacon; Clement J McDonald; Neil R Powe; Kimberly A Smith; Jenna Norton; Desmond E Williams; Uptal D Patel; Andrew Narva Journal: Clin J Am Soc Nephrol Date: 2015-06-25 Impact factor: 8.237
Authors: Ian H de Boer; Csaba P Kovesdy; Sankar D Navaneethan; Carmen A Peralta; Delphine S Tuot; Miguel A Vazquez; Deidra C Crews Journal: J Am Soc Nephrol Date: 2016-06-09 Impact factor: 10.121
Authors: Danielle Cooney; Helen Moon; Yang Liu; Richard Tyler Miller; Adam Perzynski; Brook Watts; Paul E Drawz Journal: BMC Nephrol Date: 2015-04-16 Impact factor: 2.388